REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 25
08/03/2016 12:11
- Part 25: For the preceding part double click ID:nRSH4027Rx
and integrity of which we rely on.Examples of sensitive information that
we protect include loss of clinical trial records (patient names and
treatments), personal information (employee bank details, home address),
intellectual property of manufacturing process and compliance, key
research science techniques, AstraZeneca property (theft) and privileged
access (rights to perform IT tasks).The size and complexity of our IT
systems, and those of our third party vendors (including outsource
providers) with whom we contract, have significantly increased over the
past decade and makes such systems potentially vulnerable to service
interruptions and security breaches from attacks by malicious third
parties, or from intentional or inadvertent actions by our employees or
vendors.
- More to follow, for following part double click ID:nRSH4027RzRecent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement